Hervé Lebrec

1.0k total citations
57 papers, 657 citations indexed

About

Hervé Lebrec is a scholar working on Immunology, Oncology and Small Animals. According to data from OpenAlex, Hervé Lebrec has authored 57 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 16 papers in Oncology and 11 papers in Small Animals. Recurrent topics in Hervé Lebrec's work include Immunotoxicology and immune responses (16 papers), CAR-T cell therapy research (14 papers) and Immune Cell Function and Interaction (12 papers). Hervé Lebrec is often cited by papers focused on Immunotoxicology and immune responses (16 papers), CAR-T cell therapy research (14 papers) and Immune Cell Function and Interaction (12 papers). Hervé Lebrec collaborates with scholars based in United States, France and Germany. Hervé Lebrec's co-authors include Marc Pallardy, Rafael Ponce, Gary R. Burleson, Saadia Kerdine‐Römer, Bradley D. Preston, Michele Hooper, Teresa L. Born, Cris Kamperschroer, Jacintha Shenton and Claude Bohuon and has published in prestigious journals such as Journal of Clinical Oncology, Nature Immunology and The Journal of Immunology.

In The Last Decade

Hervé Lebrec

53 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hervé Lebrec United States 16 308 142 137 88 66 57 657
Aurelia Walczak‐Drzewiecka Poland 17 253 0.8× 84 0.6× 256 1.9× 36 0.4× 71 1.1× 31 625
Rehab Monir Samaka Egypt 13 75 0.2× 139 1.0× 232 1.7× 30 0.3× 103 1.6× 84 706
Helga Tuschl Austria 16 193 0.6× 40 0.3× 153 1.1× 62 0.7× 143 2.2× 31 706
Yo Kawakubo Japan 15 227 0.7× 43 0.3× 126 0.9× 19 0.2× 88 1.3× 33 703
J. L. Granda United States 14 114 0.4× 82 0.6× 289 2.1× 23 0.3× 129 2.0× 27 845
Alessandra Fiore Italy 15 201 0.7× 136 1.0× 370 2.7× 12 0.1× 142 2.2× 34 889
Avninder Singh India 16 96 0.3× 139 1.0× 188 1.4× 16 0.2× 51 0.8× 53 821
Carlton L. Schwab United States 22 303 1.0× 339 2.4× 316 2.3× 17 0.2× 130 2.0× 43 1.1k
Youxian Li Japan 8 247 0.8× 103 0.7× 185 1.4× 8 0.1× 89 1.3× 10 667
Stanley T. Parish United States 10 192 0.6× 80 0.6× 88 0.6× 70 0.8× 44 0.7× 15 495

Countries citing papers authored by Hervé Lebrec

Since Specialization
Citations

This map shows the geographic impact of Hervé Lebrec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Lebrec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Lebrec more than expected).

Fields of papers citing papers by Hervé Lebrec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Lebrec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Lebrec. The network helps show where Hervé Lebrec may publish in the future.

Co-authorship network of co-authors of Hervé Lebrec

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Lebrec. A scholar is included among the top collaborators of Hervé Lebrec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Lebrec. Hervé Lebrec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebrec, Hervé, John Bui, Jonathan M. Clingan, et al.. (2025). Second generation CD2-targeting LFA-3 fusion protein SBT115301 to restore immune homeostasis in autoimmune disease. iScience. 28(5). 112447–112447.
2.
Kowli, Sangeeta, Sheroy Minocherhomji, Olivia M. Martinez, et al.. (2025). Characterization of immune phenotypes in peripheral blood of adult renal transplant recipients using mass cytometry (CyTOF). ImmunoHorizons. 9(4). 1 indexed citations
3.
Pallardy, Marc, Rami Bechara, Jessica Whritenour, et al.. (2024). Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis. Toxicological Sciences. 200(1). 11–30. 7 indexed citations
4.
Germolec, Dori R., Hervé Lebrec, Stacey E. Anderson, et al.. (2022). Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification. Environmental Health Perspectives. 130(10). 105001–105001. 29 indexed citations
5.
McBride, Helen J., Vincent Chow, Palanisamy Kanakaraj, et al.. (2021). Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. Biologicals. 72. 42–53. 2 indexed citations
6.
Chow, Vincent, et al.. (2021). Use of nonclinical toxicity studies to support biosimilar antibody development. Regulatory Toxicology and Pharmacology. 122. 104912–104912. 3 indexed citations
7.
Goyos, Ana, Madeline Fort, Amy Sharma, & Hervé Lebrec. (2019). Current Concepts in Natural Killer Cell Biology and Application to Drug Safety Assessments. Toxicological Sciences. 170(1). 10–19. 4 indexed citations
8.
Fielden, Mark R., Lucas D. Ward, Sheroy Minocherhomji, et al.. (2017). Modernizing Human Cancer Risk Assessment of Therapeutics. Trends in Pharmacological Sciences. 39(3). 232–247. 14 indexed citations
9.
Subramanian, Raju, Keith Bailey, Dan Branstetter, et al.. (2014). P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors. Toxicological Sciences. 142(1). 298–310. 6 indexed citations
10.
Kamperschroer, Cris, Amitinder Kaur, & Hervé Lebrec. (2012). A summary of meeting proceedings for ‘Measuring immune responses in non-human primates for drug development—Opportunities and challenges for predicting human efficacy and immunotoxicity’. Journal of Immunotoxicology. 9(1). 108–120. 6 indexed citations
11.
Lebrec, Hervé, Raegan O’Lone, Wendy Freebern, Wendy Komocsar, & Peter F. Moore. (2011). Survey: Immune function and immunotoxicity assessment in dogs. Journal of Immunotoxicology. 9(1). 1–14. 12 indexed citations
12.
Piccotti, Joseph R., Hervé Lebrec, Ellen W. Evans, et al.. (2009). Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs. Journal of Immunotoxicology. 6(1). 1–10. 6 indexed citations
13.
Weaver, James L., Jacques Descotes, Dori R. Germolec, et al.. (2005). Evaluation of a Lymph Node Proliferation Assay for its Ability to Detect Pharmaceuticals with Potential to Cause Immune-Mediated Drug Reactions. Journal of Immunotoxicology. 2(1). 11–20. 34 indexed citations
14.
Gardier, Alain M., et al.. (2000). Interaction Between the Serotoninergic and Dopaminergic Systems in d‐Fenfluramine‐Induced Activation of c‐fos and junB Genes in Rat Striatal Neurons. Journal of Neurochemistry. 74(4). 1363–1373. 22 indexed citations
15.
Kerdine‐Römer, Saadia, et al.. (1999). Quantitation of Cytokine mRNA Expression as an Endpoint for Prediction and Diagnosis of Xenobiotic-Induced Hypersensitivity Reactions. Methods. 19(1). 64–70. 7 indexed citations
16.
Kerdine‐Römer, Saadia, et al.. (1996). Interleukin‐10 and interleukin‐4 have similar effects on hapten‐specific primary antibody responses to penicillin in vivo. European Journal of Immunology. 26(12). 2890–2894. 8 indexed citations
17.
Kerdine‐Römer, Saadia, Hervé Lebrec, Jacques Bertoglio, & Marc Pallardy. (1996). Interleukin-4 plays a dominant role in Th1- or Th2-like responses during the primary immune response to the hapten penicillin. Molecular Immunology. 33(1). 71–77. 18 indexed citations
18.
19.
Lebrec, Hervé. (1994). Immunotoxicological Investigation Using Pharmaceutical Drugs: In Vivo Evaluation of Immune Effects. Fundamental and Applied Toxicology. 23(2). 159–168. 21 indexed citations
20.
Pallardy, Marc, Z. Mishal, Hervé Lebrec, & Claude Bohuon. (1992). Immune modification due to chemical interference with transmembrane signalling: Application to polycyclic aromatic hydrocarbons. International Journal of Immunopharmacology. 14(3). 377–382. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aurelia Walczak‐Drzewiecka Breakdown of academic impact, for papers by Rehab Monir Samaka Breakdown of academic impact, for papers by Helga Tuschl Breakdown of academic impact, for papers by Yo Kawakubo Breakdown of academic impact, for papers by J. L. Granda Breakdown of academic impact, for papers by Alessandra Fiore Breakdown of academic impact, for papers by Avninder Singh Breakdown of academic impact, for papers by Carlton L. Schwab Breakdown of academic impact, for papers by Youxian Li Breakdown of academic impact, for papers by Stanley T. Parish
Rankless by CCL
2026